慢性淋巴细胞白血病中亚克隆结构与突变复杂性的临床影响
该研究对406例初治慢性淋巴细胞白血病(CLL)患者及48份连续样本进行深度靶向二代测序,评估28个驱动基因的突变状态与拷贝数改变(CNA)。发现几乎所有基因(26/28)存在小亚克隆突变,CNA倾向于早期获得且保持稳定,而突变异质性在部分肿瘤中增加。驱动基因改变的累积(突变复杂性)独立于克隆结构、IGHV状态和Binet分期逐渐缩短首次治疗时间;总生存与肿瘤亚克隆多样性增加相关,但与患者年龄、IGHV及TP53状态有关。
要点
- 小亚克隆突变(占细胞0.6-25%)见于几乎所有驱动基因(26/28),在22%的突变病例中为唯一改变。
- 驱动基因改变累积(突变复杂性)独立于克隆结构、IGHV状态和Binet分期缩短首次治疗时间。
- 总生存与肿瘤亚克隆多样性增加相关,但与患者年龄、IGHV及TP53状态有关。
核心结论
- 突变复杂性和亚克隆多样性均影响慢性淋巴细胞白血病的演变。
研究设计与样本
- 对406例初治慢性淋巴细胞白血病患者及48份连续样本,采用深度靶向二代测序评估28个驱动基因突变状态及拷贝数改变(CNA)。
主要发现
- 在几乎所有基因(26/28)中检测到小亚克隆突变(占细胞0.6-25%),且在22%的突变病例中为唯一改变。
- CNA倾向于在疾病演变早期获得并保持稳定,而突变异质性在部分肿瘤中增加。
- 不同基因的预后影响与突变克隆的大小相关。
- 驱动基因改变累积(突变复杂性)独立于克隆结构、IGHV状态和Binet分期逐渐缩短首次治疗时间。
- 总生存与肿瘤亚克隆多样性增加相关,但与患者年龄、IGHV及TP53状态有关。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Genome studies of chronic lymphocytic leukemia (CLL) have revealed the remarkable subclonal heterogeneity of the tumors, but the clinical implications of this phenomenon are not well known. We assessed the mutational status of 28 CLL driver genes by deep-targeted next-generation sequencing and copy number alterations (CNA) in 406 previously untreated patients and 48 sequential samples. We detected small subclonal mutations (0.6-25% of cells) in nearly all genes (26/28), and they were the sole alteration in 22% of the mutated cases. CNA tended to be acquired early in the evolution of the disease and remained stable, whereas the mutational heterogeneity increased in a subset of tumors. The prognostic impact of different genes was related to the size of the mutated clone. Combining mutations and CNA, we observed that the accumulation of driver alterations (mutational complexity) gradually shortened the time to first treatment independently of the clonal architecture, IGHV status and Binet stage. Conversely, the overall survival was associated with the increasing subclonal diversity of the tumors but it was related to the age of patients, IGHV and TP53 status of the tumors. In conclusion, our study reveals that both the mutational complexity and subclonal diversity influence the evolution of CLL.
引用
- Nadeu F, Clot G, Delgado J, et al. Clinical impact of the subclonal architecture and mutational complexity in chronic lymphocytic leukemia. Leukemia. 2017. PMID: 28924241. doi:10.1038/leu.2017.291
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。